Major Depressive Disorder Pipeline Insights Report, 2024 Featuring 75+ Companies and Pipeline Drugs, Including SAGE-217 (Sage Therapeutics) and REL-1017 (Relmada Therapeutics)
08 mai 2024 04h43 HE
|
Research and Markets
Dublin, May 08, 2024 (GLOBE NEWSWIRE) -- The "Major Depressive Disorder - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides...
Major Depressive Disorder Market Report 2022-2032: Insight, Epidemiology and Market Forecasts - Emerging Drugs, Pipeline Activities, Therapies, Drugs Uptake
23 juin 2022 06h43 HE
|
Research and Markets
Dublin, June 23, 2022 (GLOBE NEWSWIRE) -- The "Major Depressive Disorder - Market Insight, Epidemiology And Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's...